CHARGE TRANSFER COMPLEXES IN ITRACONAZOLE
DOI:
https://doi.org/10.24113/ijoscience.v2i6.98Keywords:
drug, human, infections, membranes, proteins, virusAbstract
Itraconazole (ITZ) is a distinguished antifungal representative that also has anticancer commotion. In this study, we recognize ITZ as a wide-ranging inhibitor of enteroviruses (e.g., poliovirus, coxsackievirus, enterovirus-71, rhinovirus). We exhibit that ITZ reduces viral RNA duplication by aiming oxy-sterol-binding protein (OSBP) and OSBP-related protein 4(ORP4). Time after time, OSW-1, a precise OSBP/ORP4 antagonist, too restrains enterovirus replication. Giveaway of OSBP inhibits virus replication, while over expression of OSBP or ORP4 offsets the antiviral belongings of ITZ and OSW-1. ITZ binds OSBP and inhibits its purpose, i.e., shuttling of cholesterol and phosphatidylinositol-4-phosphate between membranes, thus likely disturbing the virus-induced membrane alterations are also indispensable for viral replication organelle construction. ITZ also inhibits hepatitis C virus replication, which also relies on OSBP. Together, these data implicate OSBP/ORP4 as molecular targets of ITZ and point to an imperative utility of OSBP/ORP4-mediated lipid barter in virus replication that can be besieged by antiviral meds.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2016 KUCHARLAPATI. DEEPTHI
This work is licensed under a Creative Commons Attribution 4.0 International License.
IJOSCIENCE follows an Open Journal Access policy. Authors retain the copyright of the original work and grant the rights of publication to the publisher with the work simultaneously licensed under a Creative Commons CC BY License that allows others to distribute, remix, adapt, and build upon your work, even commercially, as long as they credit you for the original creation. Authors are permitted to post their work in institutional repositories, social media or other platforms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
